Largest Shareholder Heecheol Kang Slightly Increases Stake via Open Market Purchase, Maintaining Management Influence Purpose


  • Heecheol Kang, the largest shareholder and CEO, purchased 9,100 shares on the open market over three days from July 9 to July 13, 2026, increasing his stake from 37.16% to 37.18%.
  • The acquisition was funded with approximately 46.4 million KRW of personal funds, reaffirming his intent to maintain influence over management.
  • The purpose of holding remains for management influence; no specific plans for executive changes or capital alterations are currently in place, but decisions will align with corporate goals.
  • [AI Summary]The minor open market purchase by the largest shareholder resulted in a 0.02%p increase in stake, but considering the change in total outstanding shares, the impact is negligible. It signals a commitment to management stability but has limited direct effect on stock price.

KOSDAQ Filing Information


  • Report on Large Shareholding (General)
  • Company: GFC Life Science (388610)
  • Submission: Heecheol Kang

  • Shares: 5,325,383
  • Price: 5,900 KRW
  • Market Cap: 31.4 B KRW